Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences:

Morgan Stanley 22nd Annual Global Healthcare Conference
Wednesday, September 4, 2024 at 10:00 a.m. ET in New York, NY

Baird’s 2024 Global Healthcare Conference
Wednesday, September 11, 2024 at 11:25 a.m. ET in New York, NY

2024 Cantor Global Healthcare Conference
Wednesday, September 18, 2024 at 10:55 a.m. ET in New York, NY

A live and achieved webcast of the presentations can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Cameron Radinovic
cradinovic@burnsmc.com
646-930-4406

Staff

Recent Posts

Catapult Health Expands Clinical Laboratory Services to All 50 States

VirtualCheckups available nationwide through employers and health plans DALLAS, Sept. 11, 2024 /PRNewswire/ -- Catapult…

30 mins ago

CORTI STRENGTHENS LEADERSHIP TEAM WITH STRATEGIC SENIOR HIRES FROM MICROSOFT AND PHILIPS

The move comes as Corti doubles down on its mission to transform overburdened healthcare systems…

30 mins ago

Veritas Labs Welcomes Healthcare Technology Trailblazer Rich Kenny as Chief Clinical Officer

SAN FRANCISCO, Sept. 11, 2024 /PRNewswire/ -- Veritas Labs, a healthcare technology company solving complex…

30 mins ago

IQVIA Applauded by Frost & Sullivan for Improving the Performance of QARA Professionals, Patient Safety, and Commercial Performance with Its AI Solutions

IQVIA's AI solutions streamline workflows, drive automation to connect process improvements, and provide insights into…

30 mins ago

IDBS honored at Asia Pacific Biologics CMO Excellence Awards 2024

WOKING, England, Sept. 11, 2024 /PRNewswire/ -- IDBS, a provider of cloud software for BioPharma…

30 mins ago

BryceTech Strengthens Biosecurity and Defense Capabilities with New Divisions

ALEXANDRIA, Va., Sept. 11, 2024 /PRNewswire/ -- In response to the increasing demand for technological…

30 mins ago